Summary
Low density lipoprotein (LDL) consists of about 3000 fatty acids (50% polyunsaturated) and a single molecule apolipoprotein B (500 kDa). The endogenous antioxidants of LDL consist mainly of tocopherols and few carotenoids, which protect the PUFAS against oxidation. That native LDL contains traces of oxidation products has not been proved yet.
Oxidatively modified LDL (oLDL) exhibits cytotoxic and chemotactic activities, furthermore it leads to foam cell formation, a critical step in atherogenesis. The oxidation of LDL is a free radical process and leads to various aldehydic products. The oxidation of LDL is initiated by cells as well as by transition metals like Cu2+. In both cases the oxidation goes through three consecutive phases. The lag-phase is characterized by minimal degradation of PUFAs but a loss of the antioxidants. Thereafter the PUFAs are oxidized to lipid hydroperoxides, which are only intermediates (propagation-phase). These intermediates will decompose to aldehydic products, accompanied by several additional changes in the LDL particle (decomposition-phase). For increased macrophage uptake oLDL must reach the late decomposition-phase; the presence of lipid hydroperoxides in LDL is not sufficient. It is suggested that binding of aldehydes to free amino groups of Apo B is the reason for macrophage uptake. This is supported by the finding that antibodies against aldehyde-modified LDL are able to recognize oxidized LDL in atherosclerotic lesions. Antioxidants like α-tocopherol are able to protect LDL against oxidation. The duration of the lag-phase shows a linear relationship with the content of α-tocopherol in LDL. Yet the efficiency of α-tocopherol to protect LDL shows strong individual variation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Avogaro, P., Bittolo-Bon, G., and Cazzolato, G. (1988) Presence of a modified low density lipoprotein in humans. Arteriosclerosis 8: 79–87.
Bedwell, S., Dean, R. T., and Jessup, W. (1989) The action of defined oxygen-centred free radical on human low-density lipoprotein. Biochem. J. 262: 707–712.
Boscoboinik, D., Szewczyk, A., Hensey, C., and Azzi, A. (1991) Inhibition of cell prohferation by a-tocopherol. J. Biol. Chem. 266: 6188–6194.
Carew, T. E., Schwenke, D. C., and Steinberg, D. (1987) Antiatherogenic effect of probucal unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density hpoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc. Natl. Acad. Sci. USA 84: 7725–7729.
Cazzolato, G., Avogaro, P., and Bittolo-Bon, G. (1991) Characterization of a more electroneg- atively charged LDL subfraction by ion exchange HPLC. Free Rad. Biol. Med. 11: 247–253.
Curzio, M., Esterbauer, H., Di Mauro, C., Cecchini, G., and Dianzani, M. U. (1986) Chemotactic activity of the Hpid peroxidation product 4-hydroxynonenal and homologous hydroxyalkenals. Biol. Chem. Hoppe-Seyler 367: 321–329.
Dieber-Rotheneder, M., Puhl, H., Wäg, G., Striegl, G., and Esterbauer, H. (1991) Effect of oral supplementation with d-alpha-tocopherol on the vitamin E content of human low density lipoproteins and its oxidation resistance. J. Lipid Res. 8: 1325–1332.
Esterbauer, H., Juergens, G., Quehenberger, O., and Koller, E. (1987) Autoxidation of human low density lipoprotein. Loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J. Lipid Res. 28: 495–509.
Esterbauer, H., Quehenberger, O., and Juergens, G. (1988) Oxidation of human low density lipoprotein with special attention to aldehydic lipid peroxidation products, in: Free Radicals: Methodology and Concepts, pp. 243–268.
Eds C. Rice-Evans and B. Halliwell. Richelieu Press, London.
Esterbauer, H., Striegl, G., Puhl, H., and Rotheneder, M. (1989a) Continous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad. Res. Commun. 6: 67–75.
Esterbauer, H., Zollner, H., and Schaur, R. J. (1989b) Aldehydes formed by lipid peroxidation: Mechanism of formation, occurrence and determination, in: Membrane Lipid Oxidation, vol. 1, pp. 239–268.
Ed. C. Vigo-Pelfrey. CRC Press, Boca Raton.
Esterbauer, H., Rotheneder, M., Waeg, G., Striedl, G., and Juergens, G. (1990a) Biochemical, structural, and functional properties of oxidized low-density lipoproteins. Chem. Res. Toxicol. 3: 77–92.
Esterbauer, H., Dieber-Rotheneder, M., Waeg, G., Puhl, H., and Tatzber, F. (1990b) Endogenous antioxidants and lipoprotein oxidation. Biochem. Soc. Trans. 18: 1059–1061.
Esterbauer, H., Dieber-Rotheneder, M., Striegl, G., and Wäg, G. (1991a) Role of vitamin E in preventing the oxidation of low density hpoprotein. Am. J. Clin. Nutr. 53: 314S-321S.
Esterbauer, H., Schaur, R. J., and Zollner, H. (1991b) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Rad. Biol. Med. 11: 81–128.
Esterbauer, H., Puhl, H., Dieber-Rotheneder, M., Waeg, G., and Rabl, H. (1991c) Effect of antioxidants on oxidative modification of LDL. Ann. Med. 23: 574–581.
Gaziano, J. M., Manson, J. E., Ridker, P. M., Buring, J. E., and Hennekens, C. H. (1990) Beta carotene for chronic stable angina. Circulation 82 (4 Suppl. Ill): 202.
Gey, K. F., and Puska, P. (1989) Plasma vitamins E and A inversely related to mortality from ischemic heart disease in cross-cultural epidemiology. Ann. N.Y. Acad. Sci. 570: 268–282.
Gey, F., Puska, P., Jordan, P., and Moser, U. K. (1991) Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am. J. CHn. Nutr. 53: 326S-334S.
Haberland, M. E., Fogelman, A. M., and Edwards, P. A. (1982) Specificity of receptor-medi- ated recognition of malondialdehyde-modified low density lipoprotein. Proc. Natl. Acad. Sci. USA 79: 1712–1716.
Haberland, M. E., Fong, D., and Cheng, L. (1988) Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 241: 215–218.
Harats, D., Ben-Naim, M., Dabach, Y., Hollander, G., Stein, O., and Stein, Y. (1989) Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages. Atherosclerosis 79: 245–252.
Hoff, H. F., Chisolm, G. M. Ill, Morel, D. W., Juergens, G., and Esterbauer, H. (1988) Chemical and functional changes in LDL following modification by 4-hydroxynonenal, in: oxy-Radicals Molecular Biology and Pathology, pp. 459–472.
Eds P. A. Cerutti, J. M. McCord and T. Fridovich. Alan R. Liss, New York.
Hoff, H. F., O’Neil, J., Chisolm, G. M., Cole, T. B., Quehenberger, O., Esterbauer, H., and Juergens, G. (1989) Modification of low-density lipoprotein with 4-hydroxynonenal induces uptake by macrophages. Arteriosclerosis 9: 538–549.
Janero, D. R. (1991) Therapeutic potential of vitamin E in the pathogenesis of spontaneous athersclerosis. Free Rad. Biol. Med. 11: 129–144.
Jessup, W., Rankin, S. M., De Whalley, C. V., Hoult, J. R. S., Scott, J., and Leake, D. S. (1990) Alpha-tocopherol consumption during low-density Hpoprotein oxidation. Biochem. J. 265: 399–405.
Juergens, G., Hoff, H. F., Chisolm, G. M., and Esterbauer, H. (1987) Modification of human serum low density lipoprotein by oxidation-characterization and pathophysiological implications. Chem. Phys. Lipids. 45: 315–336.
Juergens, G., Ashy, A., and Esterbauer, H. (1990) Detection of new epitopes formed upon oxidation of low-density lipoprotein, lipoprotein (a) and very-low-density lipoprotein. Use of an antiserum against 4-hydroxynonenal-modified low-density lipoprotein. Biochem. J. 265: 605–608.
Kaneko, T., Kaji, K., and Matsuo, M. (1988) Cytotoxicities of a linoleic acid hydroperoxide and its related aliphatic aldehydes toward cultured human umbilical vein endothelial cells. Chem.-Biol. Interact. 67: 295–304.
Kita, T., Nagano, Y., Yokode, M., Ishii, K., Kume, N., Narumiya, S., and Kawai, C. (1988) Prevention of atherosclerotic progession in Watanabe rabbits by probucol. Am. J. Cardiol. 62: 13B-19B.
Liu, S. K., Dolensek, E. P., and Tappe, J. P. (1984) Cardiomyopathy associated with vitamin E deficiency in seven gelada baboons. J. Am. Vet. Med. Assoc. 185: 1347–1350.
Mino, M., Miki, M., Miyake, M., and Ogihara, T. (1989) Nutritional assessment of vitamin E in oxidative stress. Ann. N.Y. Acad. Sci. 570: 296–310.
Morel, D. W., DiCorleto, P. E., and Chisolm, G. M. (1984) Endothelial and smooth muscle cells alter low density hpoprotein in vitro by free radical oxidation. Arteriosclerosis 4: 357–364.
Morel, D. W., and Chisolm, G. M. (1989) Antioxidant treatment of diabetic rats inhibits Hpoprotein oxidation and cytotoxicity. J. Lipid Res. 30: 1827–1834.
Palinski, W., Rosenfeld, M. E., Ylä-Herttuala, S., Gurtner, G. C., Socher, S. S., Butler, S. W., Parthasarathy, S., Carew, T. E., Steinberg, D., and Witztum, J. L. (1989) Low density Hpoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA 86: 1372–1376.
Parthasarathy, S., Young, S. G., Witztum, J. L., Pittman, R. C., and Steinberg, D. (1986) Probucol inhibits oxidative modification of low density Hpoprotein. J. CHn. Invest. 7: 641–644.
Quinn, M. T., Parthasarathy, S., Fong, L. G., and Steinberg, D. (1987) Oxidatively modified low density Hpoproteins: A potential role in recruitment and retention of monocyte/ macrophages during atherogenesis. Proc. Natl. Acad. Sci. USA 84: 2995–2998.
Riemersma, R. A., Wood, D. A., Macintyre, C. C. A., Elton, R. A., Gey, K. F., and Oliver, M. F. (1991) Risk of angina pectoris and plasma concentrations of vitamins A, C and E and carotene. Lancet 337: 1–5.
Rosenfeld, M. E., PaHnski, W., Ylä-Herttuala, S., Butler, S., and Witztum, J. L. (1990) Distribution of oxidation specific Hpid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis 10: 336–349.
Smith, T. L., and Kummerow, F. A. (1989) Effect of dietary vitamin E on plasma Hpids and atherogenesis in restricted ovulatory chickens. Atherosclerosis 75: 105–109.
Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., and Witztum, J. L. (1989) Beyond cholesterol. Modifications of low-density Hpoprotein that increase its atherogenicity. J. Engl. J. Med. 302: 915–924.
Steinbrecher, U. P., Parathasarathy, S., Leake, D. S., Witztum J. L., and Steinberg, D. (1984) Modification of low density Hpoprotein by endothelial cells involves Hpid peroxidation and degradation of low density Hpoprotein phospholipids. Proc. Natl. Acad. Sci. USA 81: 3883–3887.
Steinbrecher, U. P. (1987) Oxidation of human low density Hpoprotein results in derivatisa- tion of lysine residues of apolipoprotein B by Hpid peroxide decomposition products. J. Biol. Chem. 262: 3603–3608.
Steinbrecher, U. P., Zhang, H., and Lougheed, M. (1990) Role of oxidatively modified LDL in atherosclerosis. Free Rad. Biol. Med. 9: 155–168.
Stocker, R., Bowry, V. W., and Frei, B. (1991) Ubiquinol-10 protects human low density Hpoprotein more efficiently against Hpid peroxidation than does a-tocopherol. Proc. Natl. Acad. Sci. USA 88: 1646–1650.
Tolonen, M., Sarna, S., Halme, M., Tuominen, S. E. J., Westermarck, T., Nordberg, U., Keinonen, M., and Schrijer, J. (1988) Antioxidant supplementation decreases TBA reac- tants in serum of elderly. Biol. Trace Element Res. 17: 221–228.
Veriangieri, A. J., and Bush, M. J. (1992) Eff’ects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis. J. Am. Coll. Nutr. 11: 131–138.
Weitzel, G., Schön, H., Gey, K. F., and Buddecke, E. (1956) Lipid-soluble vitamins and atherosclerosis. Hoppe Seylers Z. Physiol. Chem. 304: 247–72
Westrope, K. L., Miller, R. A., and Wilson, R. B. (1982) Vitamin E in a rabbit model of endogenous hypercholesterolemia and atherosclerosis. Nutr. Reports Int. 25: 83–88.
Wilson, R. B., Middleton, C. C., and Sun, G. Y. (1978) Vitamin E antioxidants and Hpid peroxidation in experimental atherosclerosis of rabbits. J. Nutr. 108: 1858–67.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Birkhäuser Verlag Basel/Switzerland
About this chapter
Cite this chapter
Esterbauer, H., Waeg, G., Puhl, H., Dieber-Rotheneder, M., Tatzber, F. (1992). Inhibition of LDL oxidation by antioxidants. In: Emerit, I., Chance, B. (eds) Free Radicals and Aging. EXS, vol 62. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-7460-1_15
Download citation
DOI: https://doi.org/10.1007/978-3-0348-7460-1_15
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-0348-7462-5
Online ISBN: 978-3-0348-7460-1
eBook Packages: Springer Book Archive